Safety and Tolerability of EO2002
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorAsociación para Evitar la Ceguera en México
About this trial
The goal of this clinical study is to assess the safety of intracameral injection of EO2002 in subjects post-cataract surgery.
Eligibility criteria
Qualifiers
Age ≥ 18 years.
Subject has uncomplicated history of cataract that has progressed to a level requiring standard cataract extraction with intraocular lens implant surgery.
Decreased endothelial cell count
Disqualifiers
Other corneal disease
Macular disease that in the investigator and/or sponsor's opinion would limit the ability of the subject to demonstrate improvement in BCVA.
Descemet membrane detachment.
History of uveitis or other ocular inflammatory disease.
Trial design
Treatments tested in this trial
- EO2002
- Sham injection
Treatment groups
32 Participants
are divided into 4 treatment groupsSponsors and collaborators
Asociación para Evitar la Ceguera en México
Lead sponsor
Emmecell
Collaborator
Source ClinicalTrials.gov